Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 6 Observational 1

Sponsor

Conditions

Carcinoma, Renal Cell 17 Kidney Neoplasms 3 Gastrointestinal Stromal Tumors 3 Neoplasms 2 Financial Stress 2 Carcinoma 2 Urogenital Neoplasms 1 Pancreatic Neuroendocrine Tumors 1 Lymphoma, Mantle-Cell 1 Kidney Diseases 1 Hypertension 1 Clear-cell metastatic renal cell carcinoma 1 Adenoma, Islet Cell 1

Interventions

Surveys and Questionnaires 1 Sunitinib 1 Sorafenib 1 Phlebotomy 1 Pancreatectomy 1 Histocompatibility Testing 1 Gefitinib 1 Everolimus 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Blood Specimen Collection 1 Biopsy, Large-Core Needle 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Adenoma, Islet Cell × Sunitinib × Clear all

NCT02264665 2023-11-13

OPALINE

Pfizer

144 enrolled 26 charts

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡